These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6443167)

  • 21. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?
    Herr HW; Sogani PC
    J Urol; 2001 Oct; 166(4):1296-9. PubMed ID: 11547061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incrusted cystitis after intravesical mitomycin C treatment.
    Llopis M; Moreno J; Botella R; Algado M
    Acta Urol Belg; 1993 Sep; 61(3):21-3. PubMed ID: 8256682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors].
    Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J
    Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658
    [No Abstract]   [Full Text] [Related]  

  • 24. Chemoprophylaxis of bladder cancer recurrence: immunological aspects.
    Corrado F; Lalanne G; Pizza GC
    Panminerva Med; 1975; 17(7-8):253-8. PubMed ID: 808781
    [No Abstract]   [Full Text] [Related]  

  • 25. [Benign bladder papillomas, prognosis and treatment. Attempt at an anatomo-clinical correlation].
    Tuchschmid D; Luzuy R; Bouzakoura C
    Helv Chir Acta; 1973 Dec; 40(5):795-801. PubMed ID: 4203751
    [No Abstract]   [Full Text] [Related]  

  • 26. Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.
    Burnand KG; Boyd PJ; Mayo ME; Shuttleworth KE; Lloyd-Davies RW
    Br J Urol; 1976 Feb; 48(1):55-9. PubMed ID: 817761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
    Zhang SX; Deng XZ; Tang XD
    Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
    [No Abstract]   [Full Text] [Related]  

  • 29. [Transurethral resection in large non-invasive tumors of the bladder].
    Sánchez de Badajoz E
    Arch Esp Urol; 1985; 38(4):393-400. PubMed ID: 4073965
    [No Abstract]   [Full Text] [Related]  

  • 30. [Adjuvant thio-tepa in the treatment of bladder papilloma. A prospective randomized study].
    Malling N; Sørensen SS
    Ugeskr Laeger; 1980 Jun; 142(26):1678-9. PubMed ID: 6773198
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tumors of the superior urinary tract and associated bladder tumors: clinical and etiological aspects].
    Bretheau D; Lechevallier E; Jean F; Rampal M; Coulange C
    Prog Urol; 1993 Dec; 3(6):979-87. PubMed ID: 8305941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The so-called benign tumors of the urinary tract].
    Rutishauser G; Klein U
    Helv Chir Acta; 1973 Dec; 40(5):667-77. PubMed ID: 4203748
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ; Burnand KG
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of urinary bladder tumors].
    Rabkova LM
    Vopr Onkol; 1967; 13(9):52-8. PubMed ID: 4971095
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials in superficial and invasive bladder cancer.
    Smith PH
    Turk J Pediatr; 1984; 26(1-4):251-63. PubMed ID: 6443168
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy in superficial neoplasms of the bladder.
    Zingg E; Sulmoni A
    S Afr Med J; 1972 Jul; 46(27):916-7. PubMed ID: 4626807
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of the combined treatment of bladder cancer patients].
    Aslamazov EG; Doldurov GS; Sarkisian IuKh; Agafonova GB
    Urol Nefrol (Mosk); 1984; (4):27-30. PubMed ID: 6474624
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
    Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
    Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.